We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Prognostic Value of Specific Biomarker in Prostate Cancer Authenticated

By LabMedica International staff writers
Posted on 20 Aug 2019
Print article
Image: The VS110 combines microscopy seamlessly with imaging to create a virtual slide that is an exact copy of the real specimen (Photo courtesy of Olympus).
Image: The VS110 combines microscopy seamlessly with imaging to create a virtual slide that is an exact copy of the real specimen (Photo courtesy of Olympus).
Prostate cancer (PC) is the most commonly diagnosed cancer in Canadian men. In men with high-risk PC, progression of the disease will lead to biochemical recurrence (BCR), distant metastases, and disease-specific mortality.

The extensively studied nuclear factor kappa B (NF-κB) pathway is involved in the regulation of inflammation and the immune response, and more recently demonstrated its importance in cancer development. The activation of the NF-κB signaling pathways can result in the progression of several types of cancer, including PC.

A large team of scientists at the Centre hospitalier de l’Université de Montréal (Montreal, QC, Canada) and their associates accessed two different multi-center tissue microarrays (TMAs) representing cohorts of patients (Test-TMA and Validation-TMA series) of the Canadian Prostate Cancer Biomarker Network (CPCBN) to validate the association between p65 nuclear frequency and PC outcomes. Immunohistochemical staining of p65 was performed on the Test-TMA and Validation-TMA series, which include PC tissues from patients treated by first-line radical prostatectomy (n = 250 and n = 1,262, respectively).

For each patient, 0.6-mm cores (3–4 of tumor tissue and 1–2 of benign adjacent tissue) were punctured from formalin-fixed paraffin-embedded blocks and transferred to receiver blocks. Four-micrometer-thick sections of each TMA block were subjected to antigen retrieval in Cell Conditioning 1 for 90 minutes and then stained using the BenchMark XT autostainer. All sections were scanned using a VS-110 microscope with a 20× 0.75 NA objective and a resolution of 0.3225 μm. Two independent observers evaluated the p65 nuclear frequency in digital images of cancer tissue and benign adjacent gland tissue.

Multivariate analysis of the Validation-TMA cohort showed that p65 nuclear frequency in cancer cells was an independent predictor of BCR using continuous (hazard ratio [HR] 1.02) and dichotomized data (HR 1.33). The team used a cutoff of 3%, and found that this biomarker was also associated with the development of bone metastases (HR 1.82) and PC-specific mortality (HR 2.63), independent of clinical parameters. BCR-free survival, bone-metastasis-free survival, and PC-specific survival were shorter for patients with higher p65 nuclear frequency.

The authors concluded that they had demonstrated the prognostic significance of nuclear p65 in two independent PC TMA cohorts that included primary tumor tissues of patients from multiple institutions. The implementation of this biomarker in the clinical workflow would allow genitourinary pathologists and clinicians to improve the identification of patients with high-risk PC. The study was published on July 2, 2019, in the journal PLOS Medicine.

Related Links:
Centre hospitalier de l’Université de Montréal

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.